Rare Mutations in XRCC2 Increase the Risk of Breast Cancer
✍ Scribed by D.J. Park; F. Lesueur; T. Nguyen-Dumont; M. Pertesi; F. Odefrey; F. Hammet; S.L. Neuhausen; E.M. John; I.L. Andrulis; M.B. Terry; M. Daly; S. Buys; F. Le Calvez-Kelm; A. Lonie; B.J. Pope; H. Tsimiklis; C. Voegele; F.M. Hilbers; N. Hoogerbrugge; A. Barroso; A. Osorio; G.G. Giles; P. Devilee; J. Benitez; J.L. Hopper; S.V. Tavtigian; D.E. Goldgar; M.C. Southey
- Book ID
- 113423206
- Publisher
- American Society of Human Genetics
- Year
- 2012
- Tongue
- English
- Weight
- 457 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0002-9297
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
About 5-10% of breast cancer cases are hereditary and attributable to mutations in several susceptibility genes from which to date only 2 have been identified: BRCA1 (17q21) and BRCA2 (13q12). However, the BRCA genes only explain about 30% of familial breast/ovarian cancer, suggesting the existence
Germline mutations in the PALB2 gene are associated with an increased risk of developing breast cancer but little is known about the frequencies of rare variants in PALB2 and the nature of the variants that influence risk. We selected participants recruited to the Women's Environment, Cancer, and Ra